Reduced Incidence of Relapse and Graft-Versus-Host Disease in Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Researchers reported that there has been a encouraging reduction in AML relapse, graft-versus-host disease, and mortality after allogeneic HSC over the past decade.